Turkey’s own COVID-19 vaccine starts with phase 1
Minister of Industry and Technology Mustafa Varank has volunteered to participate in phase 1 with a vaccine candidate against COVID-19 being developed at Ankara Oncology Hospital.
Varank received the first dose of the vaccine based on virus-like particles.
The work on this special vaccine candidate was rolled out on March 27 with a total of 37 volunteers, and the researchers at the center asked me to support their efforts. I had promised to volunteer [for the tests] and today I fulfilled my promise, “Varank told reporters.
The work of developing the injection at Ankara Oncology Hospital is
being carried out under the auspices of the Scientific and Technological Research Council of Turkey (TÜBİTAK) COVID-19 Platform.
In addition to Varank, Professor Hasan Mandal, head of TÜBİTAK, also received a dose of the vaccine as a volunteer.
“If we find enough volunteers by the end of the year, we will be able to offer this vaccine to the world,” said Varank.
Phase 2 studies for the candidate vaccine are set to begin on May 2, according to Professor Fevzi Altuntaş, head of Ankara Oncology Training and Research Hospital.
Turkey has been working on developing different types of vaccines, including one in the form of nasal sprays.
The country launched the vaccination program against COVID-19 on 14 January. It originally used the injection developed by the Chinese pharmaceutical company Sinovac, but recently began administering the Pfizer / BioNTech vaccine.
To date, almost 20 million doses of coronavirus vaccines have been administered in Turkey, and around 12.1 million people have received the first dose. Almost 7.8 million people have received both doses.